EP 1429732 A1 20040623 - A CORE FORMULATION
Title (en)
A CORE FORMULATION
Title (de)
KERNFORMULIERUNG
Title (fr)
FORMULATION DE NOYAU
Publication
Application
Priority
US 0121676 W 20010710
Abstract (en)
[origin: WO03005991A1] This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
IPC 1-7
IPC 8 full level
A61K 9/28 (2006.01); A61K 9/24 (2006.01); A61K 31/155 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP)
A61K 9/209 (2013.01); A61K 31/155 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2017.12)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03005991 A1 20030123; AU 2001273310 B2 20041007; CA 2453784 A1 20030123; EP 1429732 A1 20040623; EP 1429732 A4 20050126; JP 2004536841 A 20041209; MX PA04000176 A 20041027
DOCDB simple family (application)
US 0121676 W 20010710; AU 2001273310 A 20010710; CA 2453784 A 20010710; EP 01952575 A 20010710; JP 2003511799 A 20010710; MX PA04000176 A 20010710